ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Financials / BCAT / forecast
ECAT (41) KYN (58) BTZ (43) BCX (45) ⌘ Pro Terminal →

BlackRock Capital Allocation Term Trust of (BCAT) 12-Month Stock Forecast & Price Target Cone

$13.63 -1.16% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $13.58

BlackRock Capital Allocation Term Trust of (BCAT) carries a Roarable Rating of D (Sell) with 44/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $1.49B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BCAT Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is BCAT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, BlackRock Capital Allocation Term Trust of (NYSE: BCAT) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 44/100 at a spot price of $13.63 (-1.16% 1D, market cap $1.49B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 5/20, and Executive Insider Alignment 9/20. Across 1097 tracked Financials issuers, BCAT ranks #821 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does BCAT compare to ECAT and KYN in the Financials sector?
▼

Within the Financials sector (Finance/Investors Services), BCAT carries a Roarable D (44/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, ECAT (BlackRock ESG Capital Allocation Term Trust of) holds a D- grade (41/100 RQD, P/E N/A, ROIC —, cap $1.46B) and KYN (Kayne Anderson Energy Infrastructure Fund Inc.) posts a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $2.02B). Among the 5-stock peer group, BCAT leads on earnings multiple (N/A) while BCAT leads on capital efficiency (— ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BCAT?
▼

For BlackRock Capital Allocation Term Trust of (BCAT), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity and sector rank #821 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $13.58 (-0.40%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 1% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (44/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-6.5% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D
025507510044
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D
Cash (11)Whales (6)SEC (13)Macro (5)CEO (9)
Each axis scored 0–20
12M PRICE TARGET CONE-6.3% Base Target
$17 Bull$13 Base$10 Bear
📬 FREE BCAT RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BCAT)Realized 20D OHLCV Swing Band: ±3.4%
Deterministic 5-Pillar Attribution (44/100 Composite)
🔍 WHY BCAT SCORES 44/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (30% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+11/20 pts (25% of score)

SEC XBRL Trailing 12 Months: 1% FCF Margin ($41.8M FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Macro Regime Fit5/20 pts (-15 pt drag)

Macro rate sensitivity & RSI-14 (52.3) create a -15 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
52
Grade C-$13.66-2.6% Next Q
Q2 (-2Q)
49
Grade D$13.31+0.8% Next Q
Q3 (-1Q)
47
Grade D$13.42+1.6% Next Q
Current
44
Grade D$13.63-6.5% Hist 90D α
Trajectory: C- (52) → D (44)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a BCAT Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While BCAT currently carries a cautious 44/100 (D) rating due to Macro Regime Fit (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($14.26) and Max Pain ($14.31) forces dealer call-delta covering toward $17.01.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BCAT• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “BCAT Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”
YES 44%NO 56%Trade / Inspect Odds →
INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your BCAT Position Size: $10,000

Shares at $13.63: 733.7 sh
$1,000$10,000$25,000$50,000$100,000
12M Bear Case FloorTarget $9.96
$7,307
$-2,693 (-26.9%)
12M Consensus BaseTarget $12.77
$9,369
$-631 (-6.3%)
12M Bull Case BreakoutTarget $17.01
$12,480
+$2,480 (+24.8%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (35 Desks)

Street Historical Accuracy: 64/100
● Strong Buy / Buy: 17● Hold: 9● Sell: 9
Wall Street FirmStance12M Target1Y AccuracyTrack Grade
Morgan StanleyInstitutional Equity DeskHOLD$1374%A
Goldman SachsSector Coverage LeadUNDERPERFORM$1669%B
JP MorganUS Large-Cap ResearchSELL$1158%C
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BCAT)

  • ✓Walkthrough of BCAT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
BCAT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -10.74%📐 HORIZONTAL RANGE
2026-11-03O $13.81H $13.81L $13.63C $13.63VOL 709.2K
RES: $16.24SUP: $12.58SMA50: $14.26SMA200: $15.02
$16.43$15.48$14.52$13.57$12.61RES $16.24SUP $12.58$13.632026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BCAT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BCAT Butterfly Map → + Track BCAT →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on BCAT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BCAT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for BCAT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BCAT)

Financials Rank #821 of 1097 ⚔️ ECAT vs BCAT Full Matrix →

1. Head-to-Head Financials Peer Comparison (BCAT vs. ECAT, KYN, BTZ, BCX)

Industry: Finance/Investors Services (37 Tracked Issuers)

Across 1097 tracked Financials securities in the Roarable RQD universe, BlackRock Capital Allocation Term Trust of (BCAT) ranks #821 by composite RQD confidence (44/100, grade D) and #485 by equity capitalization ($1.49B). Within this direct 5-issuer industry benchmark cohort, BCAT leads on earnings valuation at N/A trailing P/E, while BCAT leads on capital efficiency and profitability with — ROIC and — gross margin. KYN currently holds the highest overall quantitative score in the immediate peer group at 58/100 (D+) compared with BCAT at 44/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
BCAT ACTIVE
BlackRock Capital Allocation Term Trust of
D 44/100 — — — -1.16% $1.49B Benchmark Subject
ECAT
BlackRock ESG Capital Allocation Term Trust of
D- 41/100 — — — +0.45% $1.46B /ecat-vs-bcat →
KYN
Kayne Anderson Energy Infrastructure Fund Inc.
D+ 58/100 — — — -3.71% $2.02B /kyn-vs-bcat →
BTZ
BlackRock Credit Allocation Income Trust
D- 43/100 — — — -0.21% $1.03B /btz-vs-bcat →
BCX
BlackRock Resources of
D 45/100 — — — -1.17% $1.01B /bcx-vs-bcat →

2. BCAT Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

BlackRock Capital Allocation Term Trust of (BCAT) operates in Finance/Investors Services (Financials) with an equity capitalization of $1.49B, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. BCAT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BCAT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, BlackRock Capital Allocation Term Trust of (NYSE: BCAT) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 44/100 at a spot price of $13.63 (-1.16% 1D, market cap $1.49B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 5/20, and Executive Insider Alignment 9/20. Across 1097 tracked Financials issuers, BCAT ranks #821 in composite RQD confidence.

How does BCAT compare to ECAT and KYN in the Financials sector?

Within the Financials sector (Finance/Investors Services), BCAT carries a Roarable D (44/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, ECAT (BlackRock ESG Capital Allocation Term Trust of) holds a D- grade (41/100 RQD, P/E N/A, ROIC —, cap $1.46B) and KYN (Kayne Anderson Energy Infrastructure Fund Inc.) posts a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $2.02B). Among the 5-stock peer group, BCAT leads on earnings multiple (N/A) while BCAT leads on capital efficiency (— ROIC).

What are the biggest fundamental strengths and SEC risk factors for BCAT?

For BlackRock Capital Allocation Term Trust of (BCAT), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity and sector rank #821 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BCAT trading relative to its 50-day, 200-day, and 52-week technical levels?

BCAT last traded at $13.63 (-1.16% on volume of 490,733 shares), positioning the stock -4.42% below its 50-day simple moving average ($14.26) and -9.25% below its 200-day simple moving average ($15.02). Across its 52-week range of $12.91 to $16.20, BCAT sits at the 21.9% percentile with a 14-day RSI of 52.3 (NEUTRAL RANGE) and an implied next-earnings move of ±3.4% ($13.17 to $14.09).

Direct Sub-Reports: BCAT RQD Cockpit BCAT 12M Forecast BCAT Earnings & Move BCAT Dividends & DRIP BCAT Insiders & 13F BCAT Whale Options BCAT Profit Sankey BCAT News & Why
ROARABLE RATING BRIEF • RQD 44/100 (D) ✓ SEC XBRL & RQD VERIFIED

BCAT — BlackRock Capital Allocation Term Trust of: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-11-03

1. Roarable Rating Brief: What This Means to a Prospective Investor

BlackRock Capital Allocation Term Trust of (BCAT) earns a live Roarable RQD composite score of 44/100, corresponding to a D letter grade (Roarable Sell) at a spot price of $13.63 (-1.16% 1D, market capitalization $1.49B).

  • Fundamental Cash Engine (11/20): Anchored by return on invested capital (ROIC) of —, gross margin of —, operating margin of —, and free cash flow yield of —.
  • Whale 13F & Options Flow (6/20) + Insider Conviction (9/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (5/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of N/A, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

BCAT is a NYSE-listed issuer classified under the Financials sector and the Finance/Investors Services industry. The profile identifies it as a publicly traded entity with a market capitalization of $1.5B. — describes its product offerings, customer base, or revenue model.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D • RQD 44/100): Established market leader in Financials with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 6/20. With Fundamental Cash Engine at 11/20 and Institutional Whale Flow at 6/20, sustained execution supports upside toward the upper end of the $12.91 – $16.20 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream and downstream dependencies, sector correlations, and 2nd-order bottlenecks cannot be mapped from the supplied data. The only sector context available is the Financials / Finance/Investors Services classification and the beta of 1.0, which implies market-level sensitivity but does not identify specific ripple pathways.

  • Key Question #1: Can BCAT sustain or expand its — operating margin and — ROIC against Finance/Investors Services peers over the next 4 quarters?
  • Key Question #2: Will free cash flow conversion (— FCF yield) strengthen balance-sheet liquidity (Altman Z-Score N/A) toward the $16.20 52-week high?
  • Key Question #3: How sensitive is BCAT's equity valuation to Financials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

BCAT Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for BlackRock Capital Allocation Term Trust of (BCAT) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to BCAT Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

BCAT Bull vs. Bear Conversation Board — What's Your Call at $13.63?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON BCAT 🐻 33% BEARISH CONVICTION
1. Pick Your Side on BCAT:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
BR BreakoutHunter RQD DEBATE OPENER • Swing & Catalyst Trader 🐂 BULLISH 🎯 Target: $17.10 (+24.0%)
📌 Pinned Debate

The forensic balance sheet pillar scores 13/20 with Piotroski F at 6/9, Altman Z at 2.5, and Debt/Equity at 0.5, the strongest support

Here is why I am bullish on BCAT here at $13.79: The forensic balance sheet pillar scores 13/20 with Piotroski F at 6/9, Altman Z at 2.5, and Debt/Equity at 0.5, the strongest support in the rating.. Compare BCAT's 0.0% operating margin and 0.0% ROIC against the rest of Finance/Investors Services. As long as cash conversion holds up, dips toward $13.10 are getting bought.

CapAlloc_Nerd 🐂 BULL

@BreakoutHunter Agree on the RQD 44/100 quality, though with 1.0 beta I'm scaling in with half-size at $13.79 and keeping dry powder in case we test $12.82.

RE RedlineAuditor RQD DEBATE OPENER • Accounting Quality Watch 🐻 BEARISH 🎯 Target: $10.34 (-25.0%)
Spot @ $13.79

Valuation & margin reality check on BCAT at $13.79 before chasing here

Sitting on the sidelines or leaning short BCAT above $13.79. Valuation & margin reality check on BCAT at $13.79 before chasing here. Until Fundamental Cash Engine (11/20) and FCF yield (0.0%) inflect higher, upside is capped near $16.20.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%